Impact of posterior pericardial drain and risk factors on late pericardial effusion after coronary artery bypass surgery.
Journal
Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752
Informations de publication
Date de publication:
01 11 2022
01 11 2022
Historique:
pubmed:
28
9
2022
medline:
19
10
2022
entrez:
27
9
2022
Statut:
ppublish
Résumé
The blood retained in posterior pericardium can trigger an inflammatory response that increases postoperative atrial fibrillations (POAFs), and it can complicate postoperative course. We retrospectively investigated the impact of a posterior pericardial drain (PPD) in reducing late postoperative pericardial effusion (pPE) and POAFs during the first 30 postoperative days. Two hundred and fifty coronary artery bypass grafting patients were divided into two groups according to the presence of a PPD in addition to the anterior one. Perioperative data and the incidence of POAF were compared. Risk factor analysis was used to determine the predictors of pPE and postpericardiotomy syndrome. Late pPE was present in 16% of all patients. It proved to be much more frequent in patients with a posterior drain (odds ratio 2.58; 95% confidence interval 1.23-5.79; P = 0.015) where it seemed to be almost mild and anterior. 'Anterior Drain' patients showed an increased rate of moderate ( P < 0.001) and posterior effusions ( P < 0.001). POAF was much more frequent in patients without a PPD (25.2 vs. 6.3%; P < 0.001). Univariate risk factor analysis revealed a significant association between late pPE and lower preoperative weight ( P = 0.003), lower preoperative and postoperative serum albumin ( P < 0.001) and a greater amount of blood transfusion ( P = 0.02). Even if a PPD is associated with a higher rate of pPE, the patients with only anterior drains were shown to have a greater amount of pericardial effusion and an increased risk of POAFs. Therefore, a PPD should be considered to improve postoperative course.
Sections du résumé
BACKGROUND
The blood retained in posterior pericardium can trigger an inflammatory response that increases postoperative atrial fibrillations (POAFs), and it can complicate postoperative course. We retrospectively investigated the impact of a posterior pericardial drain (PPD) in reducing late postoperative pericardial effusion (pPE) and POAFs during the first 30 postoperative days.
METHODS
Two hundred and fifty coronary artery bypass grafting patients were divided into two groups according to the presence of a PPD in addition to the anterior one. Perioperative data and the incidence of POAF were compared. Risk factor analysis was used to determine the predictors of pPE and postpericardiotomy syndrome.
RESULTS
Late pPE was present in 16% of all patients. It proved to be much more frequent in patients with a posterior drain (odds ratio 2.58; 95% confidence interval 1.23-5.79; P = 0.015) where it seemed to be almost mild and anterior. 'Anterior Drain' patients showed an increased rate of moderate ( P < 0.001) and posterior effusions ( P < 0.001). POAF was much more frequent in patients without a PPD (25.2 vs. 6.3%; P < 0.001). Univariate risk factor analysis revealed a significant association between late pPE and lower preoperative weight ( P = 0.003), lower preoperative and postoperative serum albumin ( P < 0.001) and a greater amount of blood transfusion ( P = 0.02).
CONCLUSION
Even if a PPD is associated with a higher rate of pPE, the patients with only anterior drains were shown to have a greater amount of pericardial effusion and an increased risk of POAFs. Therefore, a PPD should be considered to improve postoperative course.
Identifiants
pubmed: 36166335
doi: 10.2459/JCM.0000000000001370
pii: 01244665-202211000-00003
doi:
Substances chimiques
Serum Albumin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
715-721Informations de copyright
Copyright © 2022 Italian Federation of Cardiology - I.F.C. All rights reserved.
Références
Balzer F, von Heymann C, Boyle EM, et al. Impact of retained blood requiring reintervention on outcomes after cardiac surgery. J Thorac Cardiovasc Surg 2016; 152:595.e4–601.e4.
Boyle EM Jr, Gillinov AM, Cohn WE, et al. Retained blood syndrome after cardiac surgery: a new look at an old problem. Innovations (Phila) 2015; 10:296–303.
Gaudino M, Anselmi A, Pavone N, Massetti M. Constrictive pericarditis after cardiac surgery. Ann Thorac Surg 2013; 95:731–736.
Lee YC, Vaz MA, Ely KA, et al. Symptomatic persistent postcoronary artery bypass graft pleural effusions requiring operative treatment: clinical and histologic features. Chest 2001; 119:795–800.
Karimov JH, Gillinov AM, Schenck L, et al. Incidence of chest tube clogging after cardiac surgery: a single-center prospective observational study. Eur J Cardiothorac Surg 2013; 44:1029–1036.
Shalli S, Saeed D, Fukamachi K, et al. Chest tube selection in cardiac and thoracic surgery: a survey of chest tube-Yrelated complications and their management. J Card Surg 2009; 24:503–509.
Gabaldo K, Sutlić Ž, Mišković D, et al. Postpericardiotomy syndrome incidence, diagnostic and treatment strategies: experience AT two collaborative centers. Acta Clin Croat 2019; 58:57–62.
van Osch D, Dieleman JM, Bunge JJ, et al. Risk factors and prognosis of postpericardiotomy syndrome in patients undergoing valve surgery. J Thorac Cardiovasc Surg 2017; 153:878.e1–885.e1.
Imazio M. The postpericardiotomy syndrome. Curr Opin Pulm Med 2012; 18:366–374.
Sousa-Uva M, Head SJ, Milojevic M, et al. 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg 2018; 53:5–33.
Pepi M, Muratori M, Barbier P, et al. Pericardial effusion after cardiac surgery: incidence, site, size, and haemodynamic consequences. Br Heart J 1994; 72:327–331.
Dieleman JM, Nierich AP, Rosseel PM, et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA 2012; 308:1761–1767.
Ashikhmina EA, Schaff HV, Sinak LJ, et al. Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management. Ann Thorac Surg 2010; 89:112–118.
Khan NK, Järvelä KM, Loisa EL, et al. Incidence, presentation and risk factors of late postoperative pericardial effusions requiring invasive treatment after cardiac surgery. Interact Cardiovasc Thorac Surg 2017; 24:835–840.
Lehto J, Gunn J, Karjalainen P, et al. Incidence and risk factors of postpericardiotomy syndrome requiring medical attention: the Finland postpericardiotomy syndrome study. J Thorac Cardiovasc Surg 2015; 149:1324–1329.
Andreasen JJ, Sørensen GV, Abrahamsen ER, et al. Early chest tube removal following cardiac surgery is associated with pleural and/or pericardial effusions requiring invasive treatment. Eur J Cardiothorac Surg 2016; 49:288–292.
Bjessmo S, Hylander S, Vedin J, et al. Comparison of three different chest drainages after coronary artery bypass surgery: a randomised trial in 150 patients. Eur J Cardiothorac Surg 2007; 31:372–375.
Conti VR. Choice of second pericardial drainage tube for posterior placement. J Thorac Cardiovasc Surg 2017; 154:512.
Kowalewski M, Gozdek M, Hagner W, Anisimowicz L. Posterior pericardial drainage by any means may improve outcomes after cardiac surgery. J Thorac Cardiovasc Surg 2017; 154:512–514.
Refat Ali M, Abdelsayed A. Does the position of the drains after open heart surgery make a difference? A clinical randomized trial. J Egypt Soc Cardiothorac Surg 2018; 26:281–286.
Gozdek M, Pawliszak W, Hagner W, et al. Systematic review and meta-analysis of randomized controlled trials assessing safety and efficacy of posterior pericardial drainage in patients undergoing heart surgery. J Thorac Cardiovasc Surg 2017; 153:865.e12–875.e12.
St-Onge S, Perrault LP, Demers P. Posterior pericardial drainage: could improving chest tube patency provide the same benefits? J Thorac Cardiovasc Surg 2017; 154:511–512.
Gaudino M, Sanna T, Ballman KV, et al. on behalf of the PALACS Investigators. Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-center, single-blind, randomized, controlled trial. Lancet 2021; [Epub ahead of print].